Topical antibiotic combination with keratolytic agent

This page covers all Topical antibiotic combination with keratolytic agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Bacterial 50S ribosome (clindamycin); oxidative damage to bacterial cell membranes (BPO).

Targets

Bacterial 50S ribosome (clindamycin); oxidative damage to bacterial cell membranes (BPO)

Marketed (1)

• Clindamycin and BPO 5% gel · Stiefel, a GSK Company · Dermatology
  Clindamycin kills acne-causing bacteria while benzoyl peroxide oxidizes and destroys bacterial cell membranes and reduces sebum production.

Patent intelligence

• topical antibiotic combination with keratolytic agent patent landscape — aggregated cliff calendar, attackable patents, originator estates